Koyama A - Search Results

1

[Report on evaluation of clinical laboratory examination of GFR and urinary protein].

Orita Y, Gejyo F, Ito Y, Kimura H, Koyama A, Shiigai T, Tanaka H, Haneda M, Hishida A, Horio U, Yanaqawa M, Kumano K, Abe S, Osawa S, Matoba K. Orita Y, et al. Among authors: koyama a. Nihon Jinzo Gakkai Shi. 2001;43(1):1-19. Nihon Jinzo Gakkai Shi. 2001. PMID: 11218313 Japanese. No abstract available.

2

Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study.

Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A. Yamagata K, et al. Among authors: koyama a. Kidney Int. 2007 Jan;71(2):159-66. doi: 10.1038/sj.ki.5002017. Epub 2006 Nov 22. Kidney Int. 2007. PMID: 17136030 Free article.

3

[Analysis of proteinuria by electrophoresis].

Ishida H, Koyama A, Narita M, Tojo S. Ishida H, et al. Among authors: koyama a. Nihon Jinzo Gakkai Shi. 1983 Jun;25(6):709-16. Nihon Jinzo Gakkai Shi. 1983. PMID: 6663833 Japanese. No abstract available.

4

[A study of microproteinuria in patients with collagen disease].

Ishii K, Koyama A, Kobayashi M, Kashiwagi H, Narita M. Ishii K, et al. Among authors: koyama a. Nihon Jinzo Gakkai Shi. 1989 Aug;31(8):827-37. Nihon Jinzo Gakkai Shi. 1989. PMID: 2593319 Japanese.

5

Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial.

Koyama A, Fujita T, Gejyo F, Origasa H, Isono M, Kurumatani H, Okada K, Kanoh H, Kiriyama T, Yamada S. Koyama A, et al. BMC Nephrol. 2015 Oct 16;16:165. doi: 10.1186/s12882-015-0130-5. BMC Nephrol. 2015. PMID: 26475266 Free PMC article. Clinical Trial.

6

[A study of microproteinuria in patients with diabetes mellitus].

Ishii K, Koyama A, Kobayahsi M, Itakura M, Kawai K, Yamashita K, Narita M. Ishii K, et al. Among authors: koyama a. Nihon Jinzo Gakkai Shi. 1989 Aug;31(8):815-25. Nihon Jinzo Gakkai Shi. 1989. PMID: 2593318 Japanese.

7

[Acute renal failure due to rhabdomyolysis--clinical investigation on our 6 cases].

Iitsuka T, Koyama A, Kobayashi M, Ohba S, Kikuchi H, Ohkoshi N, Narita M, Tojo S. Iitsuka T, et al. Among authors: koyama a. Nihon Jinzo Gakkai Shi. 1992 Mar;34(3):317-24. Nihon Jinzo Gakkai Shi. 1992. PMID: 1630034 Japanese.

8

Improvement of renal function in AA type amyloidosis by prolonged treatment with dimethylsulfoxide (DMSO).

Kobayashi M, Nagase S, Aoyagi K, Koyama A, Narita M, Tojo S. Kobayashi M, et al. Among authors: koyama a. Nihon Jinzo Gakkai Shi. 1987 Mar;29(3):357-61. Nihon Jinzo Gakkai Shi. 1987. PMID: 3613260 No abstract available.

9

Clinical guidelines of IgA nephropathy.

Sakai H, Abe K, Kobayashi Y, Koyama A, Shigematsu H, Harada T, Yoshikawa N, Arakawa M, Itoh H, Osawa G, et al. Sakai H, et al. Among authors: koyama a. Nihon Jinzo Gakkai Shi. 1995 Aug;37(8):417-21. Nihon Jinzo Gakkai Shi. 1995. PMID: 7563948 Review. No abstract available.

10

Effects of the antiplatelet agents, dipyridamole and dilazep dihydrochloride, on in vivo platelet function and proteinuria.

Inage H, Koyama A, Narita M, Tojo S. Inage H, et al. Among authors: koyama a. Nihon Jinzo Gakkai Shi. 1985 Sep;27(9):1261-70. Nihon Jinzo Gakkai Shi. 1985. PMID: 4087547 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

762 results

Search Page